参考文献/References:
[1] Kakarougkas A,Jeggo PA.DNA DSB repair pathway choice:an orchestrated handover mechanism[J].Br J Radiol,2014,87(1035):20130685.DOI:10.1259/bjr.20130685.
[2] Keijzers G,Maynard S,Shamanna RA,et al.The role of RecQ helicases in non-homologous end-joining[J].Crit Rev Biochem Mol Biol,2014,49(6):463-472.DOI:10.3109/10409238.2014.942450.
[3] Huang H,Song TJ,Li X,et al.BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage[J].Proc Natl Acad Sci U S A,2009,106(31):12670-12675.DOI:10.1073/pnas.0906266106.
[4] Ghaben AL,Scherer PE.Adipogenesis and metabolic health[J].Nat Rev Mol Cell Biol,2019,20(4):242-258.DOI:10.1038/s41580-018-0093-z.
[5] Gharibi B,Ghuman M,Hughes FJ.DDIT4 regulates mesenchymal stem cell fate by mediating between HIF1α and mTOR signalling[J].Sci Rep,2016,6:36889.DOI:10.1038/srep36889.
[6] Rivera-Gonzalez GC,Klopot A,Sabin K,et al.Regulated in Development and DNA Damage Responses 1 Prevents Dermal Adipocyte Differentiation and Is Required for Hair Cycle-Dependent Dermal Adipose Expansion[J].J Invest Dermatol,2020,140(9):1698-1705.e1.DOI:10.1016/j.jid.2019.12.033.
[7] Huang Q,Liu M,Du X,et al.Role of p53 in preadipocyte differentiation[J].Cell Biol Int,2014,38(12):1384-1393.DOI:10.1002/cbin.10334.
[8] Tyner SD,Venkatachalam S,Choi J,et al.p53 mutant mice that display early ageing-associated phenotypes[J].Nature,2002,415(6867):45-53.DOI:10.1038/415045a.
[9] Rauch A,Thiel CT,Schindler D,et al.Mutations in the pericentrin(PCNT)gene cause primordial dwarfism[J].Science,2008,319(5864):816-819.DOI:10.1126/science.1151174.
[10] Huang-Doran I,Bicknell LS,Finucane FM,et al.Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes[J].Diabetes,2011,60(3):925-935.DOI: 10.2337/db10-1334.
[11] Oshima J,Sidorova JM,Monnat RJ Jr.Werner syndrome: clinical features, pathogenesis and potential therapeutic interventions[J].Ageing Res Rev,2017,33:105-114.DOI:10.1016/j.arr.2016.03.002.
[12] Yokote K,Chanprasert S,Lee L,et al.WRN mutation update: mutation spectrum, patient registries, and translational prospects[J].Hum Mutat,2017,38(1):7-15.DOI:10.1002/humu.23128.
[13] Mukherjee S,Sinha D,Bhattacharya S,et al.Werner Syndrome Protein and DNA Replication[J].Int J Mol Sci,2018,19(11):3442.DOI:10.3390/ijms19113442.
[14] Goh KJ,Chen JH,Rocha N,et al.Human pluripotent stem cell-based models suggest preadipocyte senescence as a possible cause of metabolic complications of Werner and Bloom Syndromes[J].Sci Rep,2020,10(1):7490.DOI:10.1038/s41598-020-64136-8.
[15] Taylor AMR,Rothblum-Oviatt C,Ellis NA,et al.Chromosome instability syndromes[J].Nat Rev Dis Primers,2019,5(1):64.DOI:10.1038/s41572-019-0113-0.
[16] Trizuljak J,Petruchová T,Blaháková I,et al.Diagnosis of Bloom Syndrome in a Patient with Short Stature, Recurrence of Malignant Lymphoma, and Consanguineous Origin[J].Mol Syndromol,2020,11(2):73-82.DOI:10.1159/000507006.
[17] Diaz A,Vogiatzi MG,Sanz MM,et al.Evaluation of short stature, carbohydrate metabolism and other endocrinopathies in Bloom's syndrome[J].Horm Res,2006,66(3):111-117.DOI:10.1159/000093826.
[18] Kline AD,Moss JF,Selicorni A,et al.Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement[J].Nat Rev Genet,2018,19(10):649-666.DOI:10.1038/s41576-018-0031-0.
[19] Avagliano L,Parenti I,Grazioli P,et al.Chromatinopathies:a focus on cornelia de lange syndrome[J].Clin Genet,2020,97(1):3-11.DOI:10.1111/cge.13674.
[20] Kawauchi S,Calof AL,Santos R, et al.Multiple organ system defects and transcriptional dysregulation in the Nipbl(+/-)mouse, a model of Cornelia de Lange Syndrome[J].PLoS Genet,2009,5(9):e1000650.DOI:10.1371/journal.pgen.1000650.
[21] Lotta LA,Gulati P,Day FR,et al.Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance[J].Nat Genet,2017,49(1):17-26.DOI:10.1038/ng.3714.